Published in Eur J Clin Microbiol Infect Dis on February 01, 2013
A Case of Meningococcal Pyomyositis in an Otherwise Healthy Adult. Open Forum Infect Dis (2016) 0.79
Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 7.17
Osteomyelitis. Lancet (2004) 6.14
Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) (2000) 4.45
Pyomyositis. Review of 205 cases in 112 patients. Am J Surg (1979) 3.45
Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med (2003) 3.31
Chronic granulomatous disease: the European experience. PLoS One (2009) 3.04
Bacterial pyomyositis in the United States. Am J Med (2004) 2.51
Primary pyomyositis. J Bone Joint Surg Am (2002) 2.42
Modern management of chronic granulomatous disease. Br J Haematol (2008) 2.05
Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936-1955). Lancet (1960) 1.83
Tropical myositis: is it an entity and what is its cause? Lancet (1983) 1.76
Community-acquired Klebsiella pneumoniae complicated skin and soft-tissue infections of extremities: emphasis on cirrhotic patients and gas formation. Infection (2008) 1.74
Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. Clin Infect Dis (2009) 1.60
Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis (2010) 1.60
Pyomyositis in a temperate climate. Presentation, diagnosis, and treatment. J Bone Joint Surg Am (1990) 1.58
Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J Clin Microbiol (2003) 1.45
Pyomyositis in patients with the human immunodeficiency virus: an unusual form of disseminated bacterial infection. Am J Med (1991) 1.43
The French national registry of primary immunodeficiency diseases. Clin Immunol (2010) 1.40
Nontropical pyomyositis in adults. Semin Arthritis Rheum (1994) 1.33
Pyomyositis: characteristics at CT and MR imaging. Radiology (1995) 1.27
Acute pyogenic iliopsoas abscess in Taiwan: clinical features, diagnosis, treatments and outcome. J Infect (2000) 1.21
Polymicrobial pyomyositis and bacteremia in a patient with AIDS. Clin Infect Dis (1994) 1.12
How does Staphylococcus aureus escape the bloodstream? Trends Microbiol (2011) 1.09
Citrobacter freundii: a newly reported cause of pyomyositis. Am J Med Sci (1990) 1.09
Pyomyositis in children and adolescents: report of 12 cases and review of the literature. J Pediatr Orthop (1999) 1.03
Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis. J Microbiol Immunol Infect (2008) 1.01
Pyomyositis caused by Yersinia enterocolitica. J Clin Microbiol (1984) 1.00
Escherichia coli pyomyositis in an immunocompromised host. WMJ (2011) 0.98
Pyomyositis. A literature review. Acta Orthop Belg (2005) 0.97
Pyomyositis in children: early diagnosis and treatment. J Pediatr Surg (2009) 0.95
Two cases of pyomyositis caused by Klebsiella pneumoniae and review of the literature. Eur J Clin Microbiol Infect Dis (2001) 0.94
Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature. Clin Infect Dis (1996) 0.94
Clinical characteristics and predictors of mortality in 67 patients with primary pyomyositis: a study from North India. Clin Rheumatol (2009) 0.93
Paecilomyces lilacinus infection in a child with chronic granulomatous disease. J Infect (1992) 0.92
Proteus pyomyositis of the piriformis muscle in a swimmer. Clin Infect Dis (1998) 0.91
Pyomyositis and hepatic abscess in association with Aeromonas hydrophila sepsis. Am J Med (1987) 0.89
Infection: musculoskeletal. Pediatr Radiol (2011) 0.87
Comparison of the clinical and laboratory features of muscle infections caused by Salmonella and those caused by other pathogens. J Infect Chemother (2001) 0.87
The spectrum of myositis and rhabdomyolysis associated with bacterial infection. J Rheumatol (1994) 0.87
Pyomyositis of the anterior tibial compartment. Clin Infect Dis (1997) 0.87
Tropical pyomyositis, a thiamine-deficiency disease. Med Hypotheses (1981) 0.82
Increased oxacillin resistance in thigh pyomyositis in diabetic patients. Clin Orthop Relat Res (2008) 0.82
Acute haematogenous community-acquired methicillin-resistant Staphylococcus aureus osteomyelitis in an adult: case report and review of literature. BMC Infect Dis (2012) 0.81
Pyomyositis due to Escherichia coli in a patient infected by HIV. Br J Rheumatol (1994) 0.81
Gram-negative bacterial pyomyositis: unique case and review. Rev Infect Dis (1989) 0.81
Stenotrophomonas maltophilia: a very rare cause of tropical pyomyositis. Int J Rheum Dis (2010) 0.81
Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Diagn Microbiol Infect Dis (2010) 0.81
Pyomyositis--with special reference to the comparison between extra- and intrapelvic muscle abscess. Southeast Asian J Trop Med Public Health (1998) 0.81
Necrotizing myositis secondary to Serratia marcescens in a renal allograft recipient. Nephron (1990) 0.80
Capnocytophaga sputigena primary iliopsoas abscess. J Med Microbiol (2010) 0.79
Pyomyositis and polyarticular septic arthritis from Hemophilus influenzae in a nonimmunocompromised adult. J Rheumatol (1987) 0.78
Klebsiella pyomyositis. Am J Med (1986) 0.78
Tropical pyomyositis. Int Surg (1983) 0.78
Fatal septicemia and pyomyositis caused by Salmonella typhi. Clin Infect Dis (2004) 0.78
Pyogenic myositis: CT evaluation. J Comput Assist Tomogr (1988) 0.76
Stenotrophomonas maltophilia septicemia with pyomyositis in a chemotherapy-treated patient. Ann Hematol (2003) 0.75
Tropical pyomyositis caused by salmonella within the gluteus maximus of a hepatitis B carrier. Orthop Nurs (2010) 0.75
Salmonella gas-forming femoral osteomyelitis and pyomyositis: the first case and review of the literature. J Med Assoc Thai (2007) 0.75
Tropical pyomyositis of the lower limbs. Arthritis Rheum (2006) 0.75
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis (2001) 12.73
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect (2012) 4.56
Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node. J Physiol (1986) 3.79
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest (2007) 3.58
CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci U S A (2001) 3.54
Treatment of older patients with mantle-cell lymphoma. N Engl J Med (2012) 3.46
Mediastinitis due to multiple resistant Corynebacterium xerosis. Clin Infect Dis (1993) 3.14
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum (2009) 2.92
Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) (1996) 2.72
The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. The HIV Infection in Newborns French Collaborative Study Group. N Engl J Med (1992) 2.66
Activation of a muscarinic receptor selectively inhibits a rapidly inactivated Ca2+ current in rat sympathetic neurons. Proc Natl Acad Sci U S A (1987) 2.54
Interactions of Listeria monocytogenes with mammalian cells during entry and actin-based movement: bacterial factors, cellular ligands and signaling. EMBO J (1998) 2.52
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47
Escherichia coli native valve endocarditis. Clin Microbiol Infect (2006) 2.28
Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect (2004) 2.13
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Clin Infect Dis (2012) 2.07
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect (2014) 2.06
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06
TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol (1999) 2.05
Masitinib is safe and effective for the treatment of canine mast cell tumors. J Vet Intern Med (2008) 2.05
Caspase activation is required for terminal erythroid differentiation. J Exp Med (2001) 1.97
Identification of clinical coagulase-negative staphylococci, isolated in microbiology laboratories, by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and two automated systems. Clin Microbiol Infect (2009) 1.88
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies. Am J Transplant (2010) 1.86
Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype. Leukemia (2001) 1.82
The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin Exp Immunol (2009) 1.81
CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology (2012) 1.80
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML). Leukemia (2006) 1.76
Haemophilus endocarditis: report of 42 cases in adults and review. Haemophilus Endocarditis Study Group. Clin Infect Dis (1997) 1.75
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect (2014) 1.70
Vezatin, a novel transmembrane protein, bridges myosin VIIA to the cadherin-catenins complex. EMBO J (2000) 1.64
A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients. Leukemia (2004) 1.63
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect (2012) 1.55
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol (2013) 1.51
Streptococcus pneumoniae endocarditis in adults. A multicenter study in France in the era of penicillin resistance (1991-1998). The Pneumococcal Endocarditis Study Group. Medicine (Baltimore) (2000) 1.50
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect (2012) 1.48
Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France. Antimicrob Agents Chemother (2010) 1.45
Antibodies to the leucine-rich repeat region of internalin block entry of Listeria monocytogenes into cells expressing E-cadherin. Infect Immun (1996) 1.45
Evaluation of the Andromas matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of aerobically growing Gram-positive bacilli. J Clin Microbiol (2012) 1.45
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect (2012) 1.41
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob Agents Chemother (2006) 1.40
Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int (2006) 1.40
Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Ann Oncol (2003) 1.40
[Management of systemic candidiasis]. Presse Med (1999) 1.39
[Systemic granulomatosis of infectious origin]. Rev Med Interne (2007) 1.38
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia. Leukemia (2011) 1.37
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect (2014) 1.36
Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders. J Clin Oncol (2001) 1.35
Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol (2000) 1.35
Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) (1995) 1.35
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis (2009) 1.30
Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006. Antimicrob Agents Chemother (2007) 1.26
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? J Antimicrob Chemother (2006) 1.26
Barium-induced blockade of the inward rectifier in calf Purkinje fibres. Pflugers Arch (1984) 1.25
MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures. Clin Microbiol Infect (2011) 1.23
Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood (2001) 1.20
Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect (2011) 1.20
Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation. Blood (2000) 1.18
Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. Blood (1999) 1.18
Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin Microbiol Infect (2007) 1.13
L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. Ann Oncol (2008) 1.13
Delayed activation of the cardiac pacemaker current and its dependence on conditioning pre-hyperpolarizations. Pflugers Arch (1983) 1.13
Native valve endocarditis caused by Staphylococcus capitis. Eur J Clin Microbiol Infect Dis (1993) 1.13
Paediatric mastocytosis: a systematic review of 1747 cases. Br J Dermatol (2015) 1.13
A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect (2010) 1.13
Acute myeloid leukaemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome. Br J Haematol (2001) 1.13
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. Br J Haematol (1998) 1.12
Polymicrobial pyomyositis and bacteremia in a patient with AIDS. Clin Infect Dis (1994) 1.12
Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome. Oncogene (2007) 1.12
FbpA, a novel multifunctional Listeria monocytogenes virulence factor. Mol Microbiol (2004) 1.11
Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and review. Transpl Infect Dis (2008) 1.11
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives. Virus Res (2001) 1.11
Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists. Clin Infect Dis (2006) 1.11
Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection. Infect Immun (2000) 1.10
Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus. J Med Microbiol (2006) 1.09
Molecular epidemiology of Streptococcus pyogenes in an area where acute pharyngotonsillitis is endemic. J Clin Microbiol (1997) 1.09
Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1999) 1.08
Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance. J Clin Microbiol (2008) 1.08
Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia. Leukemia (2006) 1.07
Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis (2001) 1.07
Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology (1997) 1.06
[Hemophagocytic syndrome]. Rev Med Interne (2002) 1.06
Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults. Antimicrob Agents Chemother (1998) 1.04
Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp Hematol (2000) 1.04
[Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases]. Rev Med Interne (2002) 1.04
Mycobacterium kansasii septic arthritis: French retrospective study of 5 years and review. Clin Infect Dis (1999) 1.03